3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
5
Neoplasms
3
Sarcoma
2
Prostatic Neoplasms
2
Neoplasms by Site
2
Multiple Myeloma
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Stomatitis
1
Rectal Diseases
1
Pancreatic Diseases
1
Oligodendroglioma
1
Neoplasms, Plasma Cell
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Motor Activity
1
Lung Neoplasms
1
Liver Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphoid
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Inflammation
1
Graft vs Host Disease
1
Gliosarcoma
1
Interventions
fludarabine phosphate
31
Cyclophosphamide
27
Mycophenolic Acid
22
Whole-Body Irradiation
21
Tacrolimus
21
ruxolitinib
19
Peripheral Blood Stem Cell Transplantation
19
Busulfan
19
Antilymphocyte Serum
16
fludarabine
14
Melphalan
12
Methotrexate
11
Cyclosporine
10
thymoglobulin
9
Cord Blood Stem Cell Transplantation
7
Sirolimus
6
Radiotherapy
6
Etoposide
6
Azacitidine
6
Stem Cell Transplantation
5
Granulocyte Colony-Stimulating Factor
5
Cyclosporins
4
pomalidomide
3
parsaclisib
3
Surveys and Questionnaires
3
Rituximab
3
Prednisone
3
Filgrastim
3
Cytarabine
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Primary Myelofibrosis
×
Ascorbic Acid
×
Clear all
No trials found.